2011
The impact of nanoparticle ligand density on dendritic-cell targeted vaccines
Bandyopadhyay A, Fine RL, Demento S, Bockenstedt LK, Fahmy TM. The impact of nanoparticle ligand density on dendritic-cell targeted vaccines. Biomaterials 2011, 32: 3094-3105. PMID: 21262534, PMCID: PMC4570971, DOI: 10.1016/j.biomaterials.2010.12.054.Peer-Reviewed Original ResearchConceptsIL-10 responsesDEC-205 receptorIL-10Cytokine responsesT cellsSubsequent T cell responsesBlockade of CD36T cell responsesAntigen delivery systemDifferential cytokine responsesScavenger receptor CD36Vaccine delivery systemDC expressionVaccine efficacyDC functionDC productionReceptor CD36Cell responsesDelivery systemOVA nanoparticlesDelivery of therapeuticsCD36AntigenReceptorsSimilar pattern
1998
Modulation of Murine Lyme Borreliosis by Interruption of the B7/CD28 T-Cell Costimulatory Pathway
Shanafelt M, Kang I, Barthold S, Bockenstedt L. Modulation of Murine Lyme Borreliosis by Interruption of the B7/CD28 T-Cell Costimulatory Pathway. Infection And Immunity 1998, 66: 266-271. PMID: 9423867, PMCID: PMC107886, DOI: 10.1128/iai.66.1.266-271.1998.Peer-Reviewed Original ResearchAbataceptAnimalsAntibodies, BacterialAntibodies, BlockingAntigens, CDAntigens, DifferentiationArthritis, InfectiousB7-1 AntigenB7-2 AntigenCD28 AntigensCTLA-4 AntigenFemaleImmunoconjugatesImmunoglobulin GInterferon-gammaInterleukin-4Lyme DiseaseLymphocyte ActivationMembrane GlycoproteinsMiceMice, Inbred BALB CSpecific Pathogen-Free OrganismsTh1 CellsTh2 CellsUp-Regulation